These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24024535)

  • 1. Psychopharmacologic treatment of refractory pediatric obsessive compulsive disorder.
    Ferren T; Palmes GK; Kaplan SG
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):509-12. PubMed ID: 24024535
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of drug therapy in the treatment of obsessive-compulsive disorders].
    Teeuwisse JM; Nolen WA
    Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2605-8. PubMed ID: 2575230
    [No Abstract]   [Full Text] [Related]  

  • 3. Raynaud’s phenomenon in a patient with schizophrenia and obsessive-compulsive disorder: a case report.
    Korkmaz S; Işik U; Korkmaz H
    Turk Psikiyatri Derg; 2011; 22(2):132-3. PubMed ID: 21780344
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1989 Feb; 31(786):13-20. PubMed ID: 2563894
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.
    da Rocha FF; Correa H
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1550-1. PubMed ID: 17692447
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is there a specific pharmacological treatment for anxiety disorders? Summary of a controversy].
    Todorov C
    Sante Ment Que; 2004; 29(1):127-36. PubMed ID: 15470568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel treatment strategies for refractory patients with obsessive-compulsive disorder].
    Nakamae T
    Seishin Shinkeigaku Zasshi; 2013; 115(9):997-1003. PubMed ID: 24228478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of obsessive compulsive neurosis: pharmacological approach.
    Ananth J
    Psychosomatics; 1976; 17(4):180-4. PubMed ID: 12532
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological factors in obsessive-compulsive disorders.
    Turner SM; Beidel DC; Nathan RS
    Psychol Bull; 1985 May; 97(3):430-50. PubMed ID: 2860681
    [No Abstract]   [Full Text] [Related]  

  • 10. Step-wise Drug Therapy for Comorbid Bipolar and Obsessive-Compulsive Disorders.
    Naguy A; Alrashidi F
    Am J Ther; 2019; 26(5):e668-e670. PubMed ID: 30418229
    [No Abstract]   [Full Text] [Related]  

  • 11. Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials.
    Skapinakis P; Papatheodorou T; Mavreas V
    Eur Neuropsychopharmacol; 2007 Jan; 17(2):79-93. PubMed ID: 16904298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophrenia.
    Zink M; Knopf U; Kuwilsky A
    Aust N Z J Psychiatry; 2007 Mar; 41(3):293-4. PubMed ID: 17464712
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of atypical antipsychotics in refractory depression and anxiety.
    Nemeroff CB
    J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacologic treatment of obsessive-compulsive disorder.
    Thorneloe WF
    J Med Assoc Ga; 1988 Nov; 77(11):825-6. PubMed ID: 3057098
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder.
    Rubio G; Jiménez-Arriero MA; Martínez-Gras I; Manzanares J; Palomo T
    J Clin Psychopharmacol; 2006 Jun; 26(3):341-4. PubMed ID: 16702907
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inadequate pharmacotherapy in patients with obsessive-compulsive disorder].
    Denys D; van Megen HJ; Westenberg HG
    Ned Tijdschr Geneeskd; 2001 May; 145(19):914-8. PubMed ID: 11387867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of anxiety disorders.
    Mavissakalian M
    J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-onset schizophrenia and obsessive-compulsive disorder in a young man with Dandy-Walker variant.
    Papazisis G; Mastrogianni A; Karastergiou A
    Schizophr Res; 2007 Jul; 93(1-3):403-5. PubMed ID: 17478081
    [No Abstract]   [Full Text] [Related]  

  • 19. A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment.
    Kawahara T; Ueda Y; Mitsuyama Y
    Psychiatry Clin Neurosci; 2000 Oct; 54(5):599-601. PubMed ID: 11043813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder].
    Salmerón JM; Alcántara AG; Barcia D
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):399-402. PubMed ID: 9972593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.